As the number and types of pediatric transplants increase and the complexity of chemotherapy regimens continues to evolve, there is a greater need for authoritative guidance, clinically actionable strategies, and easy-to-find information in the challenging area of immunocompromised pediatric patients. Pediatric Transplant and Oncology Infectious Diseases offers up-to-date, targeted coverage of this complex field, compiled by world-renowned editors and authors into one convenient volume.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Ifc - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. iii 8. Preface - p. iii 9. Foreword - p. iii 10. Contents - p. iii 11. List of Illustrations - p. iii 12. List of Tables - p. iii 13. SECTION 1: General Immunocompromised Host Infection Principles - p. iii 14. Chapter 1: The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient - p. iii 15. Chapter 2: Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient - p. 9 16. Chapter 3: Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient - p. 21 17. SECTION 2: Common Immunocompromised Host Infection Situations - p. 33 18. Chapter 4: Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant - p. 33 19. Chapter 5: Donor screening and donor-derived infections - p. 39 20. Chapter 6: Prevention of infections in the hematopoietic stem cell transplant recipient - p. 45 21. Chapter 7: Prevention of infections in the solid organ transplantation recipient - p. 53 22. Chapter 8: Management principles for patients with neutropenia - p. 55 23. Chapter 9: Vaccination issues for transplantation and chemotherapy - p. 62 24. Chapter 10: Microbiome implications in transplantation and oncology - p. 70 25. Chapter 11: Antimicrobial stewardship in immunocompromised hosts - p. 77 26. Chapter 12: Hospital infection prevention for pediatric transplant recipients and oncology patients - p. 81 27. Chapter 13: Safe living after transplantation or chemotherapy - p. 89 28. SECTION 3: Specific Infections in Transplant Recipients and Oncology Patients - p. 96 29. Chapter 14: Multidrug-resistant gram-negative infections in transplant and oncology patients - p. 96 30. Chapter 15: Bartonella, legionella, mycoplasma, and ureaplasma - p. 102 31. Chapter 16: Nontuberculous and tuberculous mycobacterium - p. 108 32. Chapter 17: Cytomegalovirus - p. 117 33. Chapter 18: Epstein-barr virus and posttransplant lymphoproliferative disorder - p. 125 34. Chapter 19: Herpes simplex and varicella-zoster viruses - p. 133 35. Chapter 20: Human herpesvirus 6, 7, and 8 - p. 141 36. Chapter 21: Respiratory viruses - p. 146 37. Chapter 22: Adenoviruses - p. 154 38. Chapter 23: Bk and other polyomavirus associated diseases in children - p. 161 39. Chapter 24: Aspergillosis - p. 169 40. Chapter 25: Mucormycosis, fusariosis, scedosporiasis, and other invasive mold diseases - p. 180 41. Chapter 26: Candidiasis - p. 194 42. Chapter 27: Cryptococcosis and other rare invasive yeasts infections - p. 205 43. Chapter 28: Histoplasmosis, blastomycosis, and coccidioidomycosis - p. 213 44. Chapter 29: Toxoplasma gondii - p. 226 45. Chapter 30: Nocardia and actinomyces - p. 232 46. Chapter 31: Pneumocystis pneumonia - p. 240 47. Chapter 32: Strongyloides, cryptosporidium, and other parasitic infections - p. 246 48. Chapter 33: Gastrointestinal viruses - p. 252 49. Chapter 34: Clostridioides difficile infection - p. 257 50. Index - p. 262 51. Ibc - p. 262
As the number and types of pediatric transplants increase and the complexity of chemotherapy regimens continues to evolve, there is a greater need for authoritative guidance, clinically actionable strategies, and easy-to-find information in the challenging area of immunocompromised pediatric patients. Pediatric Transplant and Oncology Infectious Diseases offers up-to-date, targeted coverage of this complex field, compiled by world-renowned editors and authors into one convenient volume.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Ifc - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. iii 8. Preface - p. iii 9. Foreword - p. iii 10. Contents - p. iii 11. List of Illustrations - p. iii 12. List of Tables - p. iii 13. SECTION 1: General Immunocompromised Host Infection Principles - p. iii 14. Chapter 1: The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient - p. iii 15. Chapter 2: Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient - p. 9 16. Chapter 3: Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient - p. 21 17. SECTION 2: Common Immunocompromised Host Infection Situations - p. 33 18. Chapter 4: Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant - p. 33 19. Chapter 5: Donor screening and donor-derived infections - p. 39 20. Chapter 6: Prevention of infections in the hematopoietic stem cell transplant recipient - p. 45 21. Chapter 7: Prevention of infections in the solid organ transplantation recipient - p. 53 22. Chapter 8: Management principles for patients with neutropenia - p. 55 23. Chapter 9: Vaccination issues for transplantation and chemotherapy - p. 62 24. Chapter 10: Microbiome implications in transplantation and oncology - p. 70 25. Chapter 11: Antimicrobial stewardship in immunocompromised hosts - p. 77 26. Chapter 12: Hospital infection prevention for pediatric transplant recipients and oncology patients - p. 81 27. Chapter 13: Safe living after transplantation or chemotherapy - p. 89 28. SECTION 3: Specific Infections in Transplant Recipients and Oncology Patients - p. 96 29. Chapter 14: Multidrug-resistant gram-negative infections in transplant and oncology patients - p. 96 30. Chapter 15: Bartonella, legionella, mycoplasma, and ureaplasma - p. 102 31. Chapter 16: Nontuberculous and tuberculous mycobacterium - p. 108 32. Chapter 17: Cytomegalovirus - p. 117 33. Chapter 18: Epstein-barr virus and posttransplant lymphoproliferative disorder - p. 125 34. Chapter 19: Herpes simplex and varicella-zoster viruses - p. 133 35. Chapter 20: Human herpesvirus 6, 7, and 8 - p. 141 36. Chapter 21: Respiratory viruses - p. 146 37. Chapter 22: Adenoviruses - p. 154 38. Chapter 23: Bk and other polyomavirus associated diseases in children - p. 161 39. Chapter 24: Aspergillosis - p. 169 40. Chapter 25: Mucormycosis, fusariosis, scedosporiasis, and other invasive mold diseases - p. 180 41. Chapter 26: Candidiasis - p. 194 42. Chapter 27: Cryptococcosis and other rare invasive yeasts infections - p. 205 43. Chapter 28: Histoplasmosis, blastomycosis, and coccidioidomycosis - p. 213 44. Chapter 29: Toxoplasma gondii - p. 226 45. Chapter 30: Nocardia and actinomyces - p. 232 46. Chapter 31: Pneumocystis pneumonia - p. 240 47. Chapter 32: Strongyloides, cryptosporidium, and other parasitic infections - p. 246 48. Chapter 33: Gastrointestinal viruses - p. 252 49. Chapter 34: Clostridioides difficile infection - p. 257 50. Index - p. 262 51. Ibc - p. 262
